Equal-weight could be way to go in 2023

In what's been a dismal year for equities, some less bad strategies are standing out, and that could give ...

December 15, 2022, 11:36 am

Is the sun setting on energy stocks?

Of primary concern within the investment community is the outperformance of energy stocks in relation to the price of oil. The energy equipment and se...

December 15, 2022, 10:18 am

Forget profit, bet on 4 stocks with increasing cash flows

Cash is the most indispensable factor for any company and provides strength and vitality. PUBGY, WIRE, AMRK and BWMN are worth buying, given their ris...

December 15, 2022, 9:02 am

Caterpillar stock is a better pick over this relatively small industry peer

We believe that Caterpillar stock is currently a better pick than its industry peer, Terex stock, given its better prospects. Although Caterpillar is ...

December 15, 2022, 9:00 am

Yes bank can fall 28%, risk-reward is not justified: kotak institutional equities

The research firm further stated that “we had been concerned about their post moratorium capital structure, ability to improve their liability franc...

December 15, 2022, 8:44 am

On the brink of collapse, bitcoin miner core scientific gets bailout offer from b. riley

Embattled bitcoin miner Core Scientific has been offered US$72mln lifeline from existing creditor B Riley in order to avoid bankruptcy. The cash inje...

December 15, 2022, 7:54 am

Fed delivered the hawkish 50bp hike, now it is the ecb’s turn

Market movers today Market focus reverts to the ECB meeting today. The stabilization in euro area core inflation in November, paired with the weakenin...

December 15, 2022, 7:20 am

Previews on snb, boe and ecb

SNB, BoE and ECB rate decisions are the focuses of the day and all are expected to deliver 50bps rate hikes. There are some talks that given SNB only ...

December 15, 2022, 5:50 am

Astrazeneca's new drug application for lynparza given more time by us fda

AstraZeneca PLC (LSE:AZN), and its US peer Merck & Co, announced that the US Food and Drug Administration (FDA) will allow more time to review the new...

December 15, 2022, 3:11 am

Will whatsapp partnership boost mercadolibre's earnings?

Latin American e-commerce specialist MercadoLibre trended lower in 2022, but could a new partnership with Meta Platforms may ...

December 15, 2022, 2:01 am

People's bank of china rate setting today - mlf expected unchanged

A Medium-term Lending Facility (MLF) roll, or partial roll, is expected today from the People's Bank of China.

The 1-year MLF rate is very l...

December 14, 2022, 11:03 pm

Economic calendar in asia - china economic activity data for november, australia jobs

It's a busy data agenda ahead.

Poor Chinese data will be discounted quickly given the moves towards reopening we've recently had are expecte...

December 14, 2022, 9:03 pm

Gold prices today fall slightly from highest level in 9 months

Gold prices stayed above ₹ 54500 and rose strongly in the last 24 hours as lower CPI data gives strong indication for Fed to slow the pace of intere...

December 14, 2022, 3:29 pm

Gcom and the maryland medical cannabis commission launch decentralized identity proof of concept

The proof of concept, a next generation medical marijuana digital registration card, is built on GCOM’s Decentralized Identity for Government platfo...

December 14, 2022, 2:01 pm

Final trades: home depot, alaska air & align technology

The "Halftime Report" traders give their top picks to watch for the second half....

December 14, 2022, 1:48 pm

Is mid-america's (maa) latest dividend hike sustainable?

Mid-America's (MAA) recent dividend hike of 12% is likely to be sustainable, given the company's operational and financial strength....

December 14, 2022, 12:02 pm

Silver could see upside in 2023: a leveraged etf to consider

Unlike gold, silver can be an intriguing metals exposure option given that it can serve as an industrial or a precious metal. Some analysts are seeing...

December 14, 2022, 11:04 am

Fed pivot may send us stocks on path to bull market

Stocks were given a shot in the arm by yesterday’s cooler-than-expected US CPI data. However, greater appetite for risk assets would still need to b...

December 14, 2022, 9:12 am

Astrazeneca attractive in near term but patent cliffs loom, says broker

AstraZeneca has a “positive catalyst path ahead” in the near term given its oncology project pipelines, according to broker Jefferies, but earning...

December 14, 2022, 8:12 am

Willow biosciences gives business outlook, key targeted milestones for 2023 to expand growth, recaps 2022 key milestones

Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) has provided shareholders with the business outlook and key targeted milestones it anticipates for 2023...

December 14, 2022, 7:39 am